Affordable Access

Distinguishing features of primary hyperparathyroidism in patients with breast cancer.

Authors
  • Axelrod, D M
  • Bockman, R S
  • Wong, G Y
  • Osborne, M P
  • Kinne, D W
  • Brennan, M F
Type
Published Article
Journal
Cancer
Publication Date
Oct 01, 1987
Volume
60
Issue
7
Pages
1620–1624
Identifiers
PMID: 3621132
Source
Medline
License
Unknown

Abstract

Thirty-five women with breast cancer and primary hyperparathyroidism (1 degree HPT) were admitted to Memorial Hospital during a 25-year period. The incidence of primary hyperparathyroidism in the breast cancer patients was similar to the incidence in the total patient population at Memorial Sloan-Kettering Cancer Center (0.15% and 0.14%, respectively). The patients with 1 degree HPT disease had clinical findings which distinguished them from those patients with cancer-related hypercalcemia. Eighty percent of the breast cancer patients with primary hyperparathyroidism had earlier stage disease (Stage 0, Stage 1, Stage 2); whereas 97% of the patients with breast cancer and hypercalcemia (not due to 1 degree HPT) had advanced disease. There appeared to be a trend towards improved survival in the breast cancer patients with primary hyperparathyroidism when compared to patients of similar stage of disease who did not have parathyroid disease.

Report this publication

Statistics

Seen <100 times